- Home
- HY vs RLAY Comparison
HY vs RLAY Comparison
Compare HY & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HY
- RLAY
- Stock Information
- Founded
- HY 1991
- RLAY 2015
- Country
- HY United States
- RLAY United States
- Employees
- HY N/A
- RLAY N/A
- Industry
- HY Construction/Ag Equipment/Trucks
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HY Industrials
- RLAY Health Care
- Exchange
- HY Nasdaq
- RLAY Nasdaq
- Market Cap
- HY 717.9M
- RLAY 610.3M
- IPO Year
- HY N/A
- RLAY 2020
- Fundamental
- Price
- HY $36.02
- RLAY $3.22
- Analyst Decision
- HY Strong Buy
- RLAY Strong Buy
- Analyst Count
- HY 1
- RLAY 12
- Target Price
- HY $70.00
- RLAY $18.45
- AVG Volume (30 Days)
- HY 71.0K
- RLAY 2.9M
- Earning Date
- HY 08-05-2025
- RLAY 08-07-2025
- Dividend Yield
- HY 4.00%
- RLAY N/A
- EPS Growth
- HY N/A
- RLAY N/A
- EPS
- HY 1.26
- RLAY N/A
- Revenue
- HY $3,950,600,000.00
- RLAY $8,355,000.00
- Revenue This Year
- HY N/A
- RLAY $17.59
- Revenue Next Year
- HY $2.55
- RLAY N/A
- P/E Ratio
- HY $29.65
- RLAY N/A
- Revenue Growth
- HY N/A
- RLAY N/A
- 52 Week Low
- HY $34.13
- RLAY $1.78
- 52 Week High
- HY $69.28
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- HY 32.53
- RLAY 39.23
- Support Level
- HY $35.50
- RLAY $3.35
- Resistance Level
- HY $42.33
- RLAY $3.58
- Average True Range (ATR)
- HY 1.61
- RLAY 0.23
- MACD
- HY -0.73
- RLAY -0.05
- Stochastic Oscillator
- HY 5.75
- RLAY 20.63
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).